Role of Trimetazidine in Coronary Artery Bypass Graft Surgery 被引量：1

Role of Trimetazidine in Coronary Artery Bypass Graft Surgery

下载PDF

导出

摘要 Trimetazidine is a drug that has been used to reduce the damage of reperfusion injury, which is a mechanism of oxidative aggression that occurs in coronary syndromes, angioplasty procedures, as well as in cardiovascular surgeries. Seeking to improve myocardial protection during procedures that involve reperfusion, attention was recently turned to research on cytoprotective drugs which act on segments of cellular metabolism, used in isolation or combined to reduce or prevent damage to the cardiac cell. The aim of this review is to objectively evaluate the effects of the drug trimetazidine (TMZ) on ischemia-reperfusion injury in coronary artery bypass graft surgery by reviewing all known studies from recent years. Trimetazidine is a drug that has been used to reduce the damage of reperfusion injury, which is a mechanism of oxidative aggression that occurs in coronary syndromes, angioplasty procedures, as well as in cardiovascular surgeries. Seeking to improve myocardial protection during procedures that involve reperfusion, attention was recently turned to research on cytoprotective drugs which act on segments of cellular metabolism, used in isolation or combined to reduce or prevent damage to the cardiac cell. The aim of this review is to objectively evaluate the effects of the drug trimetazidine (TMZ) on ischemia-reperfusion injury in coronary artery bypass graft surgery by reviewing all known studies from recent years.

作者 Gerez Fernandes Martins Gerez Martins

机构地区 Cardiac Surgery Department Cardiology Department

出处《World Journal of Cardiovascular Surgery》 2017年第7期87-102,共16页 心血管外科国际期刊（英文）

关键词 ISCHEMIA-REPERFUSION Injury Oxidative Stress Inflammation TRIMETAZIDINE CORONARY ARTERY BYPASS GRAFT Ischemia-Reperfusion Injury Oxidative Stress Inflammation Trimetazidine Coronary Artery Bypass Graft

分类号 R54 [医药卫生—心血管疾病]

引文网络
相关文献

参考文献1

1陈韵岱,赵立坤,田峰,杜志民,江洪,魏盟.曲美他嗪对冠状动脉介入治疗患者的心脏保护作用[J].中华内科杂志,2010,49(6):473-476. 被引量：30

二级参考文献16

1Schiano P,Gabriel Steg P.Measurement and prevention of myocardial injury during percutaneous coronary intervention.Heart,2007,93:656-657.
2Kantor PF,Lucien A,Kozak R,et al.The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase.Circ Res,2000,86:580-588.
3Lavanchy N,Martin J,Rossi A.Anti-ischemic effects of trimetazidine:31P-NMR spectroscopy in the isolated rat heart.Arch Int Pharmacodyn Ther,1987,286:97-110.
4Renaud JF.Internal pH,Na +,and Ca2 + regulation by trimetazidine during cardiac cell acidosis.Cardiovasc Drugs Ther,1988,1:677-686.
5Cuamieri C,Muscari C.Effect of trimetazidine on mitochondrial function and oxidative damage during reperfusion of ischemic hypertrophied rat myocardium.Pharmacology,1993,46:324-331.
6Boucher FR,Hearse DJ,Opie LH.Effects of trimetazidine on ischemic contracture in isolated perfused rat hearts.J Cardiovasc Pharmacol,1994,24:45-49.
7Belcher PR,Drake-Holland AJ,Hynd JW,et al.Effects of trimetazidine on in vivo coronary arterial platelet thrombosis.Cardiovasc Drugs Ther,1993,7:149-157.
8Williams FM,Tanda K,Kus M,et al.Trimetazidine inhibits neutrophil accumulation after myocardial ischaemia and reperfusion in rabbits.J Cardiovasc Pharmacol,1993,22:828-833.
9Kantor PF,Lucien A,Kozak R,et al.The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial longchain 3-ketoacyl coenzyme A thiolase.Circ Res,2000,86:580-588.
10Lopaschuk GD,Barr R,Thomas PD,et al.Beneficial effects of trimetazidine in ex vivo working ischemic hearts are due to a stimulation of glucose oxidation secondary to inhibition of longchain 3-ketoacyl coenzyme a thiolase.Circ Res,2003,93:e33-37.